Global Biotechnology Instrumentation Market Worth Usd 6.9 Billion by 2018

Biotechnology is a vast field of applied science dealing with manufacturing useful products from biological agents or derivatives thereof. Biotechnology, which often inevitably overlaps with fields such as biomanufacturing, bioengineering, and biomedical engineering, is used to produce several products useful for mankind, such as genetically modified food and vaccines. The field originated in the early 20th century, while major developments occurred in the second half of the century, as man’s knowledge about genetics and the applicability of biological systems for the benefit of mankind grew by leaps and bounds.

Based on technology, biotechnology instrumentation is used in electrophoresis, immunoassays, microarray technology, and imaging. Imaging dominates the biotechnology instrumentation market based on technology with the largest share, followed by electrophoresis. These and other biotechnology techniques have gained prominence in fields such as drug discovery and delivery and personalized medicine in recent years. The incorporation of emergent fields such as recombinant DNA technology, genomics, and advanced applied immunology has helped the biotechnology instrumentation market massively. Based on the end users, biotechnology Instrumentation market is broadly classified into three categories namely; pharmaceutical companies, research institutes and biotech companies. Pharmaceutical and biotechnological companies held maximum share of the market.
With the advancement of science and technology and people’s living standards improve, the global biotechnology instrumentation market is expected to reach about USD 6.9 billion. North America is the largest market of biotechnology instrumentation, followed by Europe, Asia is the fastest growing market of biotechnology instrumentation.
Some key players in the market are the following:
Company | Website | Country |
Affymetrix | http://www.affymetrix.com/ | U.S. |
Agilent
Technologies | http://www.agilent.com/...